We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$232M
AUM Growth
-$7.38M
Cap. Flow
-$16.7M
Cap. Flow %
-7.19%
Top 10 Hldgs %
29.39%
Holding
116
New
2
Increased
6
Reduced
34
Closed
9

Top Buys

Rank Stock Value
1
TVRD
Tvardi Therapeutics
TVRD
+$3.76M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
+$523K
3
PVH icon
PVH
PVH
+$327K
4
CMCSA icon
Comcast
CMCSA
+$58.7K
5
NFLX icon
Netflix
NFLX
+$11.4K

Top Sells

Rank Stock Value
1
AGTC
Applied Genetic Technologies Corporation
AGTC
+$4.54M
2
QCOM icon
Qualcomm
QCOM
+$2.2M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$1.71M
4
KKR icon
KKR & Co
KKR
+$1.63M
5
MGNX icon
MacroGenics
MGNX
+$1.32M

Sector Composition

Rank Sector Weight
1 Healthcare 29.01%
2 Communication Services 22.71%
3 Energy 13.38%
4 Industrials 12.54%
5 Technology 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTX.WS
101
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
– –
-72,341
Closed -$61K
JUNO
102
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-27,900
Closed -$1.14M
SUNE
103
DELISTED
SUNEDISON, INC COM
SUNE
– –
-126,115
Closed -$906K
1 2 3 4
5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Private Capital Advisors held 116 positions worth $232M, down 3.1% from $239M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Private Capital Advisors withdrew a net $16.7M in Q4 2015, closing 9 positions and reducing 34 holdings. Its most notable exit was MacroGenics, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Energy.

Against the trend, Private Capital Advisors opened a new position in Tvardi Therapeutics worth $4.16M.

  • Private Capital Advisors's largest Q4 2015 buy was Tvardi Therapeutics: 6,857 shares worth $4.16M.
  • Private Capital Advisors added most to Rocket Pharmaceuticals in Q4 2015, an estimated $523K increase.
  • Private Capital Advisors's biggest Q4 2015 reduction was Applied Genetic Technologies Corporation, cutting an estimated $4.54M.
  • Private Capital Advisors fully exited MacroGenics in Q4 2015, selling an estimated $1.32M.
  • Private Capital Advisors's ten largest holdings make up 29% of its $232M portfolio in Q4 2015.
  • Private Capital Advisors opened 2 new positions and closed 9 in Q4 2015.
  • Private Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $232M.

Based on Private Capital Advisors's 13F filing for Q4 2015, filed 22 Jan 2016.